Treatment of Badhirya(Sensory Neural Hearing Loss)with Bilwadi taila Karnapurana and Sarivadi vati with and without Shadabindu taila Nasya

FURTHER STUDY ON EFFICACY OF BILWADI TAILA KARNAPURANA AND SARIVADI VATI WITH AND WITHOUT SHADABINDU TAILA NASYA IN THE MANAGEMENT OF BADHIRYA(SENSORY NEURAL HEARING LOSS)-AN OPEN LABELLED RANDOMISED COMPARATIVE CLINICAL TRIAL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/12/029899

Enrollment

Registered

2020-12-18

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H832- Labyrinthine dysfunction

Interventions

Intervention1: 1.Bilwadi Taila karnapurana 2.Sarivadi Vati orally 3.Shadabindu Taila Nasya: 1.Bilwadi taila Karnapurana ,24-26 Drops 100 Matra (approx 2-3 min)at evening for 30 days 2.sarivadi vati

Eligibility

Inclusion criteria

Inclusion criteria: Patients in the age group 18-60 years irrespective of sex, caste, religion etc. Degree of hearing loss (Between 25 dB to 90 dB Sensory Neural Hearing Loss)

Exclusion criteria

Exclusion criteria: Age :- below 18 year and above 60 year Degree of hearing loss greater than 90 dB Conductive deafness Mixed hearing loss Middle ear pathology Inner ear pathology like Acoustic Neuroma, Meniereâ??s disease. Genetic Sensory Neural Hearing Loss Syphilitic Sensory Neural Hearing Loss Psychogenic hearing loss Systemic diseases: e.g. Diabetes, Hypothyroidism, Renal disorders, Autoimmune disorders, Multiple sclerosis. Malignancy. Patient who need surgical intervention ï?? Age :- below 18 year and above 60 year Degree of hearing loss greater than 90 dB Conductive deafness Mixed hearing loss Middle ear pathology Inner ear pathology like Acoustic Neuroma, Meniereâ??s disease. Genetic Sensory Neural Hearing Loss Syphilitic Sensory Neural Hearing Loss Psychogenic hearing loss Systemic diseases: e.g. Diabetes, Hypothyroidism, Renal disorders, Autoimmune disorders, Multiple sclerosis. Malignancy. Patient who need surgical intervention

Design outcomes

Primary

Measure	Time frame
Relief in sign and symptoms of Badhirya after 4 weeksTimepoint: Relief in sign and symptoms of Badhirya after 4 weeks	—

Secondary

Measure	Time frame
Improvement in quality of life and social wellbeing of PatientsTimepoint: within 4 weeks from the trial	—

Countries

India

Contacts

Public ContactDr D B Vaghela

Institute for Post Graduate Teaching and Research in Ayurveda Gujarat Ayurveda University Jamnagar

drvaghela@rediffmail.com9825407899

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026